UpFront

Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)

Developer of rapid diagnostic tests designed for stroke identification. UpFront is based in Cambridge, United Kingdom and was founded in 2017. Its last reported valuation was $36.5 million in May 2025. It has raised $7.1 million.

Last reported valuation
$36.5M
Oct 2026
Priced at
—
Total raised
$7.1M
Last round
—

Who backs UpFront?

9 investors
InvestorType
Innovate UKOther
Accelerate Cambridge—
APEX Ventures—
Creator Fund—
PanaceaStars—
Phoenix Sustainable Investments—
SBRI Healthcare—
Santander Universities Entrepreneurship Awards—
West Midlands Health Tech Innovation Accelerator—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

UpFront investors

9 investors are on record for UpFront, including Innovate UK, Accelerate Cambridge, APEX Ventures and Creator Fund.

Free account
More of UpFront with a free account
  • ·Watch UpFront: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like UpFront. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View